MERIT MEDICAL SYSTEMS INC·4

May 7, 4:07 PM ET

Voigt Michel J. 4

4 · MERIT MEDICAL SYSTEMS INC · Filed May 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Merit Medical (MMSI) CHRO Michel Voigt Buys 2,250 Shares

What Happened

  • Michel J. Voigt, Chief Human Resources Officer of Merit Medical Systems, purchased 2,250 shares of MMSI stock in an open-market transaction on 2026-05-05. The shares were bought at $60.65 each for a total purchase value of approximately $136,463. This was a purchase (transaction code P), which investors often view as a more informative signal than routine sales.

Key Details

  • Transaction date and price: 2026-05-05 — 2,250 shares at $60.65 per share; total ≈ $136,463.
  • Filing date: Form 4 filed 2026-05-07 (within the typical 2-business-day reporting window).
  • Shares owned after transaction: Not specified in the filing; footnote F1 indicates plan holdings are reported as of 05/05/2026.
  • Footnotes included in the filing:
    • F1: Represents plan holdings as of 05/05/2026.
    • F2–F4: Describe vesting schedules for other option awards (become exercisable in equal annual 25% installments commencing 03/19/2022, 02/28/2023, and 02/28/2024).
  • Transaction type: Open-market purchase (code P). No 10% owner designation or gift/withholding codes noted.

Context

  • This was a straightforward open-market purchase — not an option exercise, gift, or tax-related withholding. Purchases by officers can indicate confidence, though filings are factual and do not explain intent. The filing appears timely.

Insider Transaction Report

Form 4
Period: 2026-05-05
Voigt Michel J.
CHIEF HUMAN RESOURCES OFFICER
Transactions
  • Purchase

    Common Stock, No Par Value

    [F1]
    2026-05-05$60.65/sh+2,250$136,4632,265 total(indirect: By 401(k))
Holdings
  • Common Stock, No Par Value

    46,127
  • Non-qualified stock options (right to buy)

    [F2]
    Exercise: $56.25From: 2022-03-19Exp: 2028-03-19Common Stock (2,420 underlying)
    2,420
  • Non-qualified stock options (right to buy)

    [F3]
    Exercise: $65.03From: 2023-02-28Exp: 2029-02-28Common Stock (4,046 underlying)
    4,046
  • Non-qualified stock options (right to buy)

    [F4]
    Exercise: $70.58From: 2024-02-28Exp: 2030-02-28Common Stock (11,076 underlying)
    11,076
Footnotes (4)
  • [F1]Represents plan holdings as of 05/05/2026.
  • [F2]Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
  • [F3]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
  • [F4]Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact|2026-05-07

Documents

1 file
  • 4
    form4-05072026_080519.xmlPrimary